logo
  • SELECT LICENSE :

  • US $4,299.00
  • US $8,599.00

Connected Healthcare Market, By Type (Healthcare IT, Healthcare Analytics, Healthcare Information Exchange), By Product (Personal Medical Devices, Software & Services) By End User (Hospital, Individual Customers and Others) opportunities and forecast 2020-2027

  • DLR2159
  • 19 September, 2020
  • Pharma & Healthcare
  • Pages: 120
  • Global
Market Overview

The demand for various wearable medical devices as well as patient monitoring systems is expected to rise over forecast period due to shifting consumer inclinations towards healthier lifestyle therefore driving the growth in coming years. Additionally, increasing incidences of various lifestyle-associated diseases needing continuous monitoring, which is anticipated to lead to upsurge in demand for connected healthcare devices during the forecast period. Furthermore, the advantages related with usage and availability of the advanced products, such as adapters, remote sensors, and connected communication devices are factors further supplementing the market growth.

Additionally, rising demand for the greater access to the patient health information is vital factor leading towards market growth. In addition, raised awareness as a result of supportive initiatives by the government and various non-profit organizations, including HIMSS i.e. Healthcare Information and Management Systems Society are expected to aid this industry with the future growth prospects. The increasing emphasis on development of progressive healthcare solutions with sufficient availability of funds is anticipated to boost R&D investments in connected health and wellness devices market. The government organizations, Healthcare Research and Quality (AHRQ), offer the funds to expand health information systems in U.S., which is likely to further fuel industry growth in the region.

Segment Overview

Healthcare analytics segment is anticipated to show profitable growth over forecast period due to the increasing pressure on the hospitals to curb the healthcare costs, availability of the big data analytics, and penetration of electronic health record (HER) systems in the medical settings. The rising need to increase value-based outcomes in healthcare sector and adoption of patient-centric approach are major factors propelling segment’s growth.

Regional Overview

In 2019, North America held a considerable share of overall market, which is credited to presence of encouraging reimbursement policies and large population using the wearable medical devices. Furthermore, the following changes in demographic trends comprising the growing elderly population and unhealthy routines are expected to drive industry growth.
Asia Pacific is recognised to grow at fastest CAGR over forecast period owing to the growing government initiatives aiming the improvisation of healthcare infrastructure.

Competitor overview

The market players are concentrating on development of technologically advanced and cost efficient devices, which offer ease to the consumers. Strategic alliances such as promotional activities, partnership agreements, and acquisitions with new product development are leading to the high market rivalry.

In May 2016, Philips Healthcare declared eHealth initiative that offers care to the patients with the chronic diseases across European region to generate awareness amongst the consumers and also to generate revenue. The above-mentioned factors are anticipated to contribute to the growth of connected healthcare devices industry in coming years.

Key Players
  1. Omron Healthcare, Inc.,
  2. McKesson Corporation,
  3. Philips Healthcare Company,
  4. GE Healthcare, Inc.,
  5. Draeger Medical Systems, Inc.,
  6. Fitbit, Inc.,
  7. St. Jude Medical, Inc.,
  8. Medtronic Plc,
  9. Aerotel Medical Systems Ltd.,
  10. Boston Scientific Corporation,
  11. Body Media, Inc,
  12. Garmin International, Inc.,
  13. Microlife Corporation,
  14. Masimo Corporation,
  15. AgaMatrix, Inc.,
  16. Apple, Inc.

Market Segmentation
By Type
  • Healthcare IT
  • Health Information Exchange
  • Healthcare Analytics
By Product
  • Personal Medical Devices
    • Insulin Pump
    • BP Monitors
    • Glucose Monitors
    • Others
  • Software & Services
    • Online Subscription
    • Fitness & Wellness app
    • Others
By End Use
  • Hospitals
  • Individual Customers
  • Others
By Geography
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • Rest of LAMEA


1 Report Prologue 14

    2 Introduction 15

    • 2.1 Scope of Study 15
    • 2.2 Research Objective 15
    • 2.3 Assumptions & Limitations 15
      • 2.3.1 Assumptions 15
      • 2.3.2 Limitations 16
    • 2.4 Market Structure 16

    3 Research Methodology 17

    • 3.1 Research Process 17
    • 3.2 Primary Research 18
    • 3.3 Secondary Research 18

    4 Market Dynamics 19

    • 4.1 Introduction 19
    • 4.2 Drivers 19
      • 4.2.1 Connected Healthcare applications has increased the involvement of patient population 19
      • 4.2.2 Increasing use of Smartphones and wearable devices into healthcare has led to the growth of the market 20
      • 4.2.3 Cost effectiveness and Patients’ Convenience will drive the connected healthcare market 20
      • 4.2.4 Continuous increase in Lifestyle Disease has led to the development of personalized healthcare solutions 20
    • 4.3 Restraints 21
      • 4.3.1 Increasing privacy and cybercrimes restraint the growth of connected healthcare market 21
      • 4.3.2 Lack of Awareness about the possible applications of connected healthcare 22
      • 4.3.3 Reluctance to share information regarding the health has limit the growth of the market 22
    • 4.4 Opportunities 22
      • 4.4.1 Growing partnership between the companies has become the entrance gateway for new firms 22
      • 4.4.2 Introduction of connected healthcare in developing economies will boost the growth of the connected healthcare 22
    • 4.5 Challenges 23
      • 4.5.1 Low rate of literacy and language barriers in low- and middle-income countries (LMICs) is a big challenge for the connected healthcare solutions 23
      • 4.5.2 Potential risk of Hardware or Software failure will barred the growth of the market 23
      • 4.5.3 Stringent Regulations and Standards will restraining the growth of the market 24

    5 Market Factor Analysis 25

    • 5.1 Connected Healthcare Device: Porter’s Five Force Analysis 25
      • 5.1.1 Bargaining Power of Buyer 26
      • 5.1.2 Bargaining Power of Supplier 27
      • 5.1.3 Threat from substitute 27
      • 5.1.4 Threat from a New Entrant 27
      • 5.1.5 Intensity of Competitive Rivalry 27
    • 5.2 Value Chain Analysis 28
      • 5.2.1 Device Manufacturers 29
      • 5.2.2 App Developers 30
      • 5.2.3 Network providers/ Mobile operators 30
      • 5.2.4 Healthcare providers and Pharmaceuticals 30
      • 5.2.5 Patients 30

    6 Connected Healthcare Market, By Types 31

    • 6.1 Introduction 32
    • 6.2 M-Health Services 32
      • 6.2.1 Mobile health Apps and Content Solution 34
        • 6.2.1.1 Software 34
        • 6.2.1.2 Big Data 34
      • 6.2.2 Network and Services/ Mobile operators 35
      • 6.2.3 Healthcare Providers and Pharmaceuticals 35
        • 6.2.3.1 Healthcare providers 35
        • 6.2.3.2 Pharmaceuticals 36
  • 6.3 M-Health Devices 36
    • 6.3.1 Medical Devices 38
      • 6.3.1.1 SMBG 39
      • 6.3.1.2 Blood Pressure Monitor 39
      • 6.3.1.3 Cardiac Monitors 40
      • 6.3.1.4 Pulse Oximeter 40
      • 6.3.1.5 Other Medical Devices 40
    • 6.3.2 Wearable Devices 41
      • 6.3.2.1 Hand Worn Products 43
        • 6.3.2.1.1 Smart Watch 43
        • 6.3.2.1.2 Wrist Wear 43
      • 6.3.2.2 Head Worn Products 43
        • 6.3.2.2.1 AR/VR HMD/HUD 43
        • 6.3.2.2.2 Others 43
      • 6.3.2.3 Body worn products 44
        • 6.3.2.3.1 Smart Textile 44
        • 6.3.2.3.2 Wearable Patch 44
        • 6.3.2.3.3 Others 45
    • 6.3.3 Connected Drug Delivery Systems 45
      • 6.3.3.1 Auto-injectors 46
      • 6.3.3.2 Inhalers 47
  • 6.4 E-Prescription 48
  • 7 Connected Healthcare Market, By Applications 50

    • 7.1 Introduction 51
    • 7.2 Monitoring Applications 53
    • 7.3 Diagnosis & Treatment 54
    • 7.4 Education & Awareness 54
    • 7.5 Healthcare Management 55
    • 7.6 Wellness & Prevention 57
    • 7.7 Other Applications 58

    8 Connected Healthcare Market, By Regions 59

    • 8.1 Introduction 60
    • 8.2 North America 62
      • 8.2.1 Introduction 62
      • 8.2.2 U.S. 64
      • 8.2.3 Canada 66
    • 8.3 Europe 68
      • 8.3.1 Introduction 68
      • 8.3.2 Germany 71
      • 8.3.3 France 72
      • 8.3.4 U.K. 73
      • 8.3.5 Italy 74
      • 8.3.6 Spain 75
    • 8.4 Asia-Pacific 76
      • 8.4.1 Introduction 76
      • 8.4.2 Japan 80
      • 8.4.3 China 82
      • 8.4.4 India 83
      • 8.4.5 Australia 85
      • 8.4.6 Republic of Korea 86
    • 8.5 Middle East & Africa 87
      • 8.5.1 Introduction 87
      • 8.5.2 Africa 88
      • 8.5.3 Middle East 88

    9 Competitive Landscape 91

    • 9.1 Introduction 91
      • 9.1.1 Partnerships, Agreements and Collaborations 92
      • 9.1.2 Product Development and Launch 94
      • 9.1.3 Approvals 97
      • 9.1.4 Acquisitions 98
      • 9.1.5 Award & Recognition 99
      • 9.1.6 Others 99

    10 Company Profile 101

    • 10.1 Agamatrix, Inc. 101
      • 10.1.1 Company Overview 101
      • 10.1.2 Product/Business Segment Overview 101
      • 10.1.3 Financial Overview 101
      • 10.1.4 Key Development 101
      • 10.1.5 SWOT Analysis 102
    • 10.2 AirStrip Technologies 103
      • 10.2.1 Company Overview 103
      • 10.2.2 Product/Business Segment Overview 103
      • 10.2.3 Financial Overview 103
      • 10.2.4 Key Development 103
      • 10.2.5 SWOT Analysis 104
    • 10.3 AliveCor Inc. 105
      • 10.3.1 Company Overview 105
      • 10.3.2 Product/Business Segment Overview 105
      • 10.3.3 Financial Overview 105
      • 10.3.4 Key Development 105
      • 10.3.5 SWOT Analysis 106
    • 10.4 Allscripts 106
      • 10.4.1 Company Overview 106
      • 10.4.2 Product/Business Segment Overview 107
      • 10.4.3 Financial Overview 107
      • 10.4.4 Key Development 109
      • 10.4.5 SWOT Analysis 109
    • 10.5 Apple Inc. 110
      • 10.5.1 Company Overview 110
      • 10.5.2 Product/Business Segment Overview 110
      • 10.5.3 Financial Overview 110
      • 10.5.4 SWOT Analysis 112
    • 10.6 Athenahealth, Inc. 113
      • 10.6.1 Company Overview 113
      • 10.6.2 Product/Business Segment Overview 113
      • 10.6.3 Financial Overview 113
      • 10.6.4 Key Development 114
      • 10.6.5 SWOT Analysis 114
    • 10.7 Boston Scientific Corporation 115
      • 10.7.1 Company Overview 115
      • 10.7.2 Product/Business Segment Overview 115
      • 10.7.3 Financial Overview 115
      • 10.7.4 Key Development 116
      • 10.7.5 SWOT Analysis 117
    • 10.8 Cerner 118
      • 10.8.1 Company Overview 118
      • 10.8.2 Product/Business Segment Overview 118
      • 10.8.3 Financial Overview 118
      • 10.8.4 Key Development 119
      • 10.8.5 SWOT Analysis 120
    • 10.9 GE Healthcare 121
      • 10.9.1 Company Overview 121
      • 10.9.2 Product/Business Segment Overview 121
      • 10.9.3 Financial Overview 121
      • 10.9.4 Key Development 123
      • 10.9.5 SWOT Analysis 123
    • 10.10 Honeywell Life Care Solutions 124
      • 10.10.1 Company Overview 124
      • 10.10.2 Product/Business Segment Overview 124
      • 10.10.3 Financial Overview 124
      • 10.10.4 Key Development 126
      • 10.10.5 SWOT Analysis 126
    • 10.11 Medtronics 127
      • 10.11.1 Company Overview 127
      • 10.11.2 Product/Business Segment Overview 127
      • 10.11.3 Financial Overview 127
      • 10.11.4 Key Development 128
      • 10.11.5 SWOT Analysis 129
    • 10.12 Microsoft 130
      • 10.12.1 Company Overview 130
      • 10.12.2 Product/Business Segment Overview 130
      • 10.12.3 Financial Overview 130
      • 10.12.4 SWOT Analysis 132
    • 10.13 Persistent Systems 133
      • 10.13.1 Company Overview 133
      • 10.13.2 Product/Business Segment Overview 133
      • 10.13.3 Financial Overview 133
      • 10.13.4 Key Development 134
      • 10.13.5 SWOT Analysis 135
    • 10.14 Koninklijke Philips N.V. 136
      • 10.14.1 Company Overview 136
      • 10.14.2 Product/Business Segment Overview 136
      • 10.14.3 Financial Overview 136
      • 10.14.4 Key Development 137
      • 10.14.5 SWOT Analysis 138
    • 10.15 Qualcomm 139
      • 10.15.1 Company Overview 139
      • 10.15.2 Product/Business Segment Overview 139
      • 10.15.3 Financial Overview 139
      • 10.15.4 Key Development 140
      • 10.15.5 SWOT Analysis 141
    • 10.16 Sanofi 142
      • 10.16.1 Company Overview 142
      • 10.16.2 Product/Business Segment Overview 142
      • 10.16.3 Financial Overview 142
      • 10.16.4 Key Development 143
      • 10.16.5 SWOT Analysis 145
    • 10.17 Vivify Health, Inc. 146
      • 10.17.1 Company Overview 146
      • 10.17.2 Product/Business Segment Overview 146
      • 10.17.3 Financial Overview 146
      • 10.17.4 SWOT Analysis 147

    11 Appendix 148

    Report You Might be Interested